Trump Considers Starlink to Restore Internet Access in Iran Amid Protests 
Rio Tinto–Glencore Merger Talks Spark Investor Debate Over Value, Strategy and Coal Exposure 
GM Takes $6 Billion EV Write-Down as Electric Vehicle Demand Slows in the U.S. 
FCC Approves Expansion of SpaceX Starlink Network With 7,500 New Satellites 
Trump Pushes $100 Billion U.S. Oil Investment Plan for Venezuela After Maduro Seizure 
FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling 
xAI Cash Burn Highlights the High Cost of Competing in Generative AI 
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move 
Allegiant to Acquire Sun Country Airlines in $1.5 Billion Deal to Expand U.S. Leisure Travel Network 
Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks 
Anthropic Launches HIPAA-Compliant Healthcare Tools for Claude AI Amid Growing Competition 
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut 
SK Hynix Shares Hit Record High as AI Memory Demand Fuels Semiconductor Rally 
Nvidia Appoints Former Google Executive Alison Wagonfeld as First Chief Marketing Officer 
Hanwha Ocean Shares Rise on Plans to Expand U.S. Shipbuilding Capacity 
NEW YORK, March 20, 2017 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Central District of California on behalf of investors who purchased NantHealth, Inc. (NASDAQ:NH) securities (1) pursuant and/or traceable to the Company’s Initial Public Offering on or about June 1, 2016; and/or (2) between June 1, 2016 and March 6, 2017.
Click here to learn about the case: http://www.wongesq.com/pslra/nanthealth-inc-nh. There is no cost or obligation to you.
According to the complaint, during the class period the Company made false and/or misleading statements and/or failed to disclose that: (1) Company founder Patrick Soon-Shiong had donated funds through nonprofit organizations to the University of Utah for the purpose of funneling those funds back into NantHealth; (2) as such, the Company and Soon-Shiong participated in the violation of federal tax laws—exposing the Company to possible civil and criminal liability; (3) the Company improperly recorded orders received from the University of Utah as GPS Cancer test orders; and (4) that, as a result, the Company reported false and inflated GPS Cancer order figures for the third quarter of 2016.
If you suffered a loss in NantHealth you have until May 8, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra/nanthealth-inc-nh.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]
